Page last updated: 2024-10-24

celecoxib and MS (Multiple Sclerosis)

celecoxib has been researched along with MS (Multiple Sclerosis) in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Celecoxib is a selective cyclooxygenase-2 (COX2) inhibitor."5.39A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation. ( Alloza, I; Chiba, A; Di Penta, A; Miyake, S; Vandenbroeck, K; Villoslada, P; Wyssenbach, A; Yamamura, T, 2013)
"The psoriatic arthritis was treated with celecoxib and multiple sclerosis with fingolimod."5.38A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart? ( Cocco, G, 2012)
"Celecoxib is a selective cyclooxygenase-2 (COX2) inhibitor."1.39A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation. ( Alloza, I; Chiba, A; Di Penta, A; Miyake, S; Vandenbroeck, K; Villoslada, P; Wyssenbach, A; Yamamura, T, 2013)
"The psoriatic arthritis was treated with celecoxib and multiple sclerosis with fingolimod."1.38A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart? ( Cocco, G, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Penta, A1
Chiba, A1
Alloza, I1
Wyssenbach, A1
Yamamura, T1
Villoslada, P1
Miyake, S1
Vandenbroeck, K1
Cocco, G1

Other Studies

2 other studies available for celecoxib and MS (Multiple Sclerosis)

ArticleYear
A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Animals; Astrocytes; Axons; Celecoxib; Cells, Cultured; Cyclooxygenase 2 Inhibitors; Cytokines; Dise

2013
A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart?
    Cardiovascular toxicology, 2012, Volume: 12, Issue:3

    Topics: Arthritis, Psoriatic; Atrial Fibrillation; Autoimmune Diseases; Celecoxib; Cyclooxygenase Inhibitors

2012